IP Library Granted Patent US 9,889,154
Granted Patent B2
US 9,889,154 · App. 14/995,592 · Granted Feb 13, 2018

Hemostatic compositions, devices, and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,889,154
App. No.
14/995,592
Granted
Feb 13, 2018
Kind
B2
Abstract

Compositions that include a clay such as kaolin dispersed in a liquid such as water may be useful for promoting the clotting of blood. The compositions may be in a liquid, gel, paste, foam, or another form. Uses may include treating a traumatic injury such as in injury caused by a bullet, an explosive, a blade etc., or an injury caused during a medical procedure such as surgery.

Claims (27)

1. A hemostatic device comprising:

an absorbent material;

a composition comprising a clay hemostatic agent and hydroxypropylmethylcellulose;

wherein the clay hemostatic agent is kaolin;

wherein the composition is suspended in a liquid to form a suspension;

wherein the suspension is absorbed onto the absorbent material during preparation of the hemostatic device; and

wherein the clay hemostatic agent comprises about 10% or less of the weight of the suspension.

2. The hemostatic device of claim 1 , wherein the absorbent material is selected from the group consisting of a sponge, a cloth, and a gauze.

3. The hemostatic device of claim 1 , wherein the hemostatic device further comprises one or more of bentonite, montmorillonite, saponite, polygorskite or attapulgite, and sepiolite.

4. A hemostatic device comprising:

an absorbent material;

a composition comprising a clay hemostatic agent and a thickening agent selected from the group consisting of hydroxypropylmethylcellulose, methylcellulose, and hydroxypropylcellulose;

wherein the clay hemostatic agent is kaolin; and

wherein the composition is suspended in a liquid and absorbed onto the absorbent material during preparation of the hemostatic device.

5. The hemostatic device of claim 4 , wherein the absorbent material is selected from the group consisting of a sponge, a cloth, and a gauze.

6. The hemostatic device of claim 4 , wherein the hemostatic device further comprises one or more of bentonite, montmorillonite, saponite, polygorskite or attapulgite, and sepiolite.

7. The hemostatic device of claim 4 , wherein the thickening agent is a gelling agent.

8. The hemostatic device of claim 4 , wherein the thickening agent is hydroxypropylmethylcellulose.

9. A hemostatic device configured to halt the flow of blood from a bleeding wound, the hemostatic device comprising:

an absorbent gauze;

a hemostatic clay applied to the gauze such that the clay is configured to be dispensed onto a bleeding wound when the hemostatic device is applied to the bleeding wound;

a composition comprising hydroxypropylmethylcellulose applied to the gauze;

wherein the hemostatic clay comprises kaolin; and

wherein the gauze is not saturated with liquid such that the gauze is capable of absorbing blood when the hemostatic device is applied to a bleeding wound.

10. The hemostatic device of claim 9 , wherein the hemostatic device is dry.

11. The hemostatic device of claim 9 , wherein the hemostatic device is provided in a sterilized package.

12. The hemostatic device of claim 9 , wherein the hydroxypropylmethylcellulose acts as a thickening agent.

Assignments (13)
SECURITY INTEREST Recorded Mar 1, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066723/0376 →
CHANGE OF NAME Recorded Feb 29, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066836/0737 →
MERGER Recorded Feb 29, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066707/0695 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066616/0701 →
MERGER Recorded Feb 16, 2024
From: TELEFLEX LIFE SCIENCES II LLC
To: TELEFLEX TECHNOLOGIES LLC
Reel/Frame 066621/0946 →
CHANGE OF NAME Recorded Feb 16, 2024
From: TELEFLEX TECHNOLOGIES LLC
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066621/0882 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: TELEFLEX LIFE SCIENCES LIMITED
To: TELEFLEX LIFE SCIENCES II LLC
Reel/Frame 066434/0248 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2022
From: Z-MEDICA, LLC
To: TELEFLEX LIFE SCIENCES LIMITED
Reel/Frame 058740/0387 →
SECURITY INTEREST Recorded Mar 2, 2021
From: Z-MEDICA, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055455/0099 →
RELEASE OF SECURITY INTEREST Recorded Jan 6, 2021
From: TWIN BROOK CAPITAL PARTNERS, LLC
To: Z-MEDICA, LLC
Reel/Frame 054832/0770 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 039222/0029 Recorded Oct 9, 2017
From: MADISON CAPITAL FUNDING LLC, AS AGENT
To: Z-MEDICA, LLC
Reel/Frame 044151/0476 →
SECURITY INTEREST Recorded Jul 22, 2016
From: Z-MEDICA, LLC
To: MADISON CAPITAL FUNDING LLC, AS AGENT
Reel/Frame 039222/0029 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2016
From: JOHNSON, BRENT A
To: Z-MEDICA, LLC
Reel/Frame 037502/0092 →